Medicalgorithmics seeks shareholder approval to issue up to 1 million shares to strategic investor at minimum PLN 33 each

• Medicalgorithmics’ management board recommends shareholder approval of two share issues at an extraordinary general meeting.
• Up to 1,000,000 series S shares would be offered to a potential strategic investor at no less than PLN 33 per share.
• That issue would exclude pre-emptive rights; the potential investor is an Asian cardiology company listed on a major Asian stock exchange.
• Existing shareholders would receive pre-emptive rights for up to 1,000,000 series R shares at PLN 20 per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicalgorithmics SA published the original content used to generate this news brief on October 22, 2026, and is solely responsible for the information contained therein.